Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells.

scientific article

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1104562242
P356DOI10.1186/S40425-018-0350-X
P932PMC publication ID6000980
P698PubMed publication ID29898782

P50authorKerry D FisherQ58227976
Len SeymourQ60020655
Egon J JacobusQ61093626
P2093author name stringSilvio Hemmi
Alice Brown
Janet Lei
Margaret R Duffy
Brian Champion
William K Taverner
Fred Lilley
Lorna Slater
Katy West
P2860cites workThe coxsackievirus and adenovirus receptor is a transmembrane component of the tight junctionQ24291966
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses.Q24522973
Translation by ribosome shunting on adenovirus and hsp70 mRNAs facilitated by complementarity to 18S rRNAQ24609345
Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and PathogensQ27664992
Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cellsQ28282385
The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3Q33201422
Directed evolution generates a novel oncolytic virus for the treatment of colon cancerQ33344440
Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35.Q33381618
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic AdenovirusQ33633287
Going viral with cancer immunotherapyQ34427647
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14.Q34781681
Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infectionQ35689715
SEC14L2 enables pan-genotype HCV replication in cell cultureQ35743753
Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c miceQ35852023
Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirusQ36184357
Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo.Q36220647
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators.Q36323413
Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes.Q36380295
Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor GrowthQ36951268
Oncolytic virotherapyQ38025263
Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategiesQ38139255
Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer.Q38713629
Oncolytic viruses-immunotherapeutics on the riseQ38919107
A mouse mammary epithelial cell line permissive for highly efficient human adenovirus growthQ39241643
Productive replication of human adenoviruses in mouse epidermal cellsQ39589975
Comparative sequence analysis of the largest E1A proteins of human and simian adenovirusesQ39753100
Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsiesQ40152125
Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targetingQ40250421
Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.Q40322147
Regulation of translation by ribosome shunting through phosphotyrosine-dependent coupling of adenovirus protein 100k to viral mRNAsQ40435988
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection.Q41706961
Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood.Q42236177
Molecular biology of adenovirus type 2 semipermissive infections. I. Viral growth and expression of viral replicative functions during restricted adenovirus infectionQ42812969
Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy.Q44729128
CD46 is a cellular receptor for group B adenovirusesQ45869560
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectimmunologyQ101929
AdenoviridaeQ193447
pharmacologyQ128406
oncolytic virusQ1560099
cancer researchQ3421914
molecular medicineQ3523816
P304page(s)55
P577publication date2018-06-13
P1433published inJournal for Immunotherapy of CancerQ27725163
P1476titleExpression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells.
P478volume6

Reverse relations

Q90736824External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increasecites workP2860

Search more.